Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MacroHint Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1437134269630013441.png) MacroHint [@MacroHint](/creator/twitter/MacroHint) on x XXX followers
Created: 2025-07-22 22:57:34 UTC

X stories. X angles. All signal, no fluff.
🩺 Why UnitedHealth’s Amedisys deal isn’t dead yet
🧬 The under-the-radar medtech stock Maverick Capital just bought
🎨 And the most colorful tech IPO of 2025: Figma ($FIG)👇 Dive in:





XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947793170936304088/c:line.svg)

**Related Topics**
[$fig](/topic/$fig)
[ipo](/topic/ipo)
[$amed](/topic/$amed)

[Post Link](https://x.com/MacroHint/status/1947793170936304088)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MacroHint Avatar MacroHint @MacroHint on x XXX followers Created: 2025-07-22 22:57:34 UTC

X stories. X angles. All signal, no fluff. 🩺 Why UnitedHealth’s Amedisys deal isn’t dead yet 🧬 The under-the-radar medtech stock Maverick Capital just bought 🎨 And the most colorful tech IPO of 2025: Figma ($FIG)👇 Dive in:

XXX engagements

Engagements Line Chart

Related Topics $fig ipo $amed

Post Link

post/tweet::1947793170936304088
/post/tweet::1947793170936304088